ADHD, stimulant use may elevate risk for cardiomyopathy for young adults healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Open-label mavacamten for a median of 62 weeks in patients with symptomatic obstructive hypertrophic cardiomyopathy showed ongoing safety and efficacy.
Focus on Heart Failure | Heart Failure and Transplantation: Key Wins in 2021 - American College of Cardiology acc.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acc.org Daily Mail and Mail on Sunday newspapers.